Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Renvela
Renvela
Impax Labs stock surges 4.4% on FDA approval of generic kidney disease medication Renvela
Marketwatch
Tue, 10/24/17 - 09:15 am
Impax Labs
FDA
kidney disease
generics
Sanofi
Renvela
Impax to Sell Authorized Generic Renvela
Yahoo/Zacks.com
Fri, 04/18/14 - 08:58 am
Impax Labs
generics
Sanofi
Renvela
chronic kidney disease
Impax Laboratories Confirms Patent Challenge Relating to RENVELA®, 2.4 g and 0.8 g (For Suspension)
Yahoo/BusinessWire
Sat, 07/3/10 - 10:06 am
Impax Labs
Genzyme
Renvela
chronic kidney disease
Watson sued by Genzyme over generic Renvela plans
Yahoo/AP
Wed, 05/26/10 - 09:00 am
Watson Pharmaceuticals
generics
Genzyme
lawsuits
Renvela
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
Seeking Alpha
Wed, 11/25/09 - 07:45 am
Genzyme
Renagel
Renvela
Another Genzyme Drug Goes Kaboom
TheStreet.com
Wed, 11/18/09 - 09:10 am
Genzyme
kidney disease
Renvela
APB
Impax Laboratories faces lawsuit from Genzyme in patent challenge to kidney drug Renvela
Yahoo/AP
Tue, 04/7/09 - 05:07 am
Impax
kidney disease
Renvela
Genzyme
patents